Johan Neyts

Johan Hendrik Neyts (born Blankenberge on 21 January 1966) is a Belgian virologist. He is head of The Neyts-lab of Virology, Antiviral Drug and Vaccine Research, which is part of the Laboratory of Virology and Chemotherapy at the Rega Institute for Medical Research, and full professor of virology at the Faculty of Medicine of KU Leuven. During the 2019-2020 coronavirus pandemic, Neyts came to national prominence as an expert on the (re)search for antiviral drugs and vaccines against SARS-CoV-2. Provided by Wikipedia
Showing 1 - 20 results of 55 for search 'Johan Neyts', query time: 0.17s Refine Results
  1. 1
    Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis [version 1; referees: 2 approved]
    by Carmen Mirabelli, Els Scheers, Johan Neyts
    Published 2017-10-01
    Get full text
    Article
  2. 2
    Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
    by Leen Delang, Lotte Coelmont, Johan Neyts
    Published 2010-03-01
    Get full text
    Article
  3. 3
    A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice
    by Robbert Boudewijns, Ji Ma, Johan Neyts, Kai Dallmeier
    Published 2021-08-01
    Get full text
    Article
  4. 4
    Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
    Get full text
    Article
  5. 5
    Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
    Get full text
    Article
  6. 6
    Screening and in vitro antiviral assessment of small molecules against fluorescent protein-expressing Bunyamwera virus in a cell-based assay using high-content imaging
    Get full text
    Article
  7. 7
    Trigocherrierin A, a Potent Inhibitor of Chikungunya Virus Replication
    Get full text
    Article
  8. 8
    Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
    Get full text
    Article
  9. 9
    Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds
    Get full text
    Article
  10. 10
    Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections
    Get full text
    Article
  11. 11
    A rat model for hepatitis E virus
    Get full text
    Article
  12. 12
    A Viral Polymerase Inhibitor Reduces Zika Virus Replication in the Reproductive Organs of Male Mice
    Get full text
    Article
  13. 13
    Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy
    Get full text
    Article
  14. 14
    Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals.
    Get full text
    Article
  15. 15
    A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
    Get full text
    Article
  16. 16
    The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.
    Get full text
    Article
  17. 17
    A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
    Get full text
    Article
  18. 18
    Antimicrobial, Anthelmintic, and Antiviral Activity of Plants Traditionally Used for Treating Infectious Disease in the Similipal Biosphere Reserve, Odisha, India
    Get full text
    Article
  19. 19
    Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells.
    Get full text
    Article
  20. 20
    Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search